These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Artificial Organs 2006: a year in review. Malchesky PS Artif Organs; 2007 Mar; 31(3):225-41. PubMed ID: 17343699 [No Abstract] [Full Text] [Related]
6. Bound and circulating heparin in an ECMO system thrombogenicity versus functionality. Roohk HV; Calabrese D; Sanematsu L; Castillo G; Cottonaro CN Trans Am Soc Artif Intern Organs; 1984; 30():639-43. PubMed ID: 6533950 [No Abstract] [Full Text] [Related]
7. Development of blood compatible elastomers. II. Performance of Avcothane blood contact surfaces in experimental animal implantations. Nyilas E J Biomed Mater Res; 1972; 6(4):97-127. PubMed ID: 5045267 [No Abstract] [Full Text] [Related]
8. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats. Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115 [TBL] [Abstract][Full Text] [Related]
9. [Changes in the blood coagulation system in pregnancy]. Kemkes-Matthes B Z Kardiol; 2001; 90 Suppl 4():45-8. PubMed ID: 11373943 [TBL] [Abstract][Full Text] [Related]
10. Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity. Major TC; Handa H; Annich GM; Bartlett RH J Biomater Appl; 2014 Oct; 29(4):479-501. PubMed ID: 24934500 [TBL] [Abstract][Full Text] [Related]
11. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation. Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580 [TBL] [Abstract][Full Text] [Related]
12. Mitigation of coagulation by removing clotting factors part 2: heparin-free extracorporeal circulation in a porcine model. Sukavaneshvar S; Parker JT; Beutler DS; Burns G; Solen KA; Mohammad SF ASAIO J; 2007; 53(4):421-7. PubMed ID: 17667225 [TBL] [Abstract][Full Text] [Related]
13. [Material design for artificial organs]. Akaike T Iyodenshi To Seitai Kogaku; 1983 Sep; 21(5):337-42. PubMed ID: 6677741 [No Abstract] [Full Text] [Related]
14. Thrombophilia of nephrotic syndrome in adults. Bramham K; Hunt BJ; Goldsmith D Clin Adv Hematol Oncol; 2009 Jun; 7(6):368-72. PubMed ID: 19606070 [No Abstract] [Full Text] [Related]
16. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit. Lucchi L; Ligabue G; Marietta M; Delnevo A; Malagoli M; Perrone S; Stipo L; Grandi F; Albertazzi A Artif Organs; 2006 Feb; 30(2):106-10. PubMed ID: 16433843 [TBL] [Abstract][Full Text] [Related]
17. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS). Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588 [TBL] [Abstract][Full Text] [Related]
19. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation. Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775 [TBL] [Abstract][Full Text] [Related]
20. [Development and production of equipment for extracorporeal blood purification in the PEHAPT Association]. Zavalishin IuK; LeshchinskiÄ GM; Noskov SG; KhaÄtlin AI Med Tekh; 1993; (2):37-41. PubMed ID: 8502155 [No Abstract] [Full Text] [Related] [Next] [New Search]